Fig. 1From: A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancerStudy design and flowchart. mCRC, metastatic colorectal cancer; ECOG, Eastern Cooperative Oncology Group; SD, stable disease; PR, partial response; CR, complete response; PD, progression of disease; PFS, progression-free survival; OS, overall survivalBack to article page